Delivery Order SPE2DB24D2106-SPE2DB24FAUJF

Award Date 6/11/24
Potential Completion Date 6/12/24
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,542.80 contract is for the delivery of 4,565,862,751 units of the prescription medication ondansetron ODT 8 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,045.09 contract is for the delivery of 4,566,450,193 units of Ondansetron HCL 4 mg tablets by November 18, 2024. The award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,292.82 firm fixed-price delivery order is for the supply of 4,566,496,580 units of ondansetron 8mg tablets. The order is not associated with any set-aside designation. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,968.95 contract is for the delivery of 4,564,878,259 tablets of 8 mg Ondansetron Orally Disintegrating Tablets. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group that allows the DLA to issue delivery orders for a wide range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,852.88, is for the delivery of 4,564,487,576 units of ondansetron orodispersible tablet, 8 milligrams, in 30-count packages. The contract does not have a set-aside designation and will run through May 1, 2024. This award is associated with DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.65 order is for 500 units of the prescription medication Ondansetron HCL 4 mg tablet. The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 held by DMS Pharmaceutical Group with DLA, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,835.84 firm fixed-price delivery order is for the supply of 4,565,044,224 units of the drug ondansetron hydrochloride. The delivery order is being fulfilled under a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,104.48, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including both common and...
This is a firm fixed-price delivery order worth $4,166.66 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, which is not associated with a set-aside designation, is for the supply of 4,566,147,997 Ondansetron HCL 4 MG Tablets in 500-count packages. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 with the DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $3,034.47, is for Ondansetron HCL 4 mg tablets in a 30-count package. The order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUJF
    Delivery Order

This is a $9,051.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,564,882,353 units of ondansetron odt 8 mg tablets, with a completion date of June 12, 2024.

DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This specific delivery order is part of that larger contract vehicle. There is no set-aside designation for this award.

Generated 9/10/24, 9:18 AM